Rash pruritic: FDA reporting patterns
53,237 FDA FAERS reports mention Rash pruritic. 24,627 reports have a serious outcome flag.
Medicines named as suspect
- Dupilumab: 4,142 reports
- Adalimumab: 4,019 reports
- Etanercept: 3,136 reports
- Lenalidomide: 2,660 reports
- Infliximab: 1,384 reports
- Methotrexate: 1,330 reports
- Ribavirin: 1,297 reports
- Telaprevir: 1,262 reports
- Rituximab: 1,136 reports
- Tocilizumab: 1,075 reports
- Abatacept: 1,066 reports
- Peginterferon Alfa-2a: 1,050 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.